全文获取类型
收费全文 | 1164篇 |
免费 | 78篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 28篇 |
妇产科学 | 7篇 |
基础医学 | 131篇 |
口腔科学 | 30篇 |
临床医学 | 374篇 |
内科学 | 210篇 |
皮肤病学 | 24篇 |
神经病学 | 45篇 |
特种医学 | 163篇 |
外科学 | 65篇 |
综合类 | 41篇 |
一般理论 | 3篇 |
预防医学 | 36篇 |
眼科学 | 5篇 |
药学 | 62篇 |
肿瘤学 | 38篇 |
出版年
2023年 | 6篇 |
2022年 | 4篇 |
2021年 | 14篇 |
2019年 | 4篇 |
2018年 | 12篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 9篇 |
2014年 | 21篇 |
2013年 | 32篇 |
2012年 | 56篇 |
2011年 | 60篇 |
2010年 | 49篇 |
2009年 | 52篇 |
2008年 | 48篇 |
2007年 | 51篇 |
2006年 | 28篇 |
2005年 | 33篇 |
2004年 | 26篇 |
2003年 | 29篇 |
2002年 | 38篇 |
2001年 | 41篇 |
2000年 | 49篇 |
1999年 | 16篇 |
1998年 | 47篇 |
1997年 | 40篇 |
1996年 | 41篇 |
1995年 | 38篇 |
1994年 | 27篇 |
1993年 | 26篇 |
1992年 | 18篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1989年 | 34篇 |
1988年 | 30篇 |
1987年 | 23篇 |
1986年 | 15篇 |
1985年 | 24篇 |
1984年 | 17篇 |
1983年 | 14篇 |
1982年 | 25篇 |
1981年 | 15篇 |
1980年 | 20篇 |
1979年 | 6篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1976年 | 12篇 |
1972年 | 5篇 |
1971年 | 5篇 |
1840年 | 8篇 |
排序方式: 共有1264条查询结果,搜索用时 15 毫秒
31.
Fourteen consecutively referred, symptomatic patients with Waldenstrom's macroglobulinemia (ages 52-87 yr) have been treated with the 5-drug M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone). Three patients were previously treated and 11 patients were untreated. The majority of patients were symptomatic from hyperviscosity. All patients have responded to therapy. Two patients have achieved complete remissions and 12 patients partial remissions to date. None of the patients with symptomatic hyperviscosity has required plasmapheresis since therapy with the M-2 has been initiated. Lymphadenopathy, hepatosplenomegaly, and anemia have also responded to treatment. Follow-up data are limited, with survival from initiation of therapy with the M-2 ranging from 2+ to 35% mo (median 17+ mo) 2+-40+ mo from time of diagnosis). Combination chemotherapy for Waldenstrom's macroglobulinemia with the M-2 protocol appears to increase the response rate in patients with symptomatic disease. Further survival analysis will be carried out. 相似文献
32.
33.
34.
35.
Zhen EY Brittain IJ Laska DA Mitchell PG Sumer EU Karsdal MA Duffin KL 《Arthritis and rheumatism》2008,58(8):2420-2431
OBJECTIVE: To identify, characterize, and compare proteolysis peptide products generated by metalloprotease digests of human articular cartilage. METHODS: Human articular cartilage was digested by the addition of exogenous metalloproteases, including matrix metalloproteinases 2, 3, 8, 9, 12, and 13 and aggrecanases ADAMTS-4 and ADAMTS-5. Proteolyzed peptide products were identified by proteomics methods using mass spectrometry. RESULTS: Complete sequences of the peptides proteolyzed from human articular cartilage, including N- and C-termini and hydroxylated posttranslational modifications, were determined. A wide variety of peptides, originating from types I, II, and III collagen, biglycan, prolargin, fibromodulin, fibronectin, decorin, cartilage oligomeric matrix protein, cartilage intermediate-layer protein, megakaryocyte-stimulating factor, mimecan, aggrecan, and lumican, was analyzed following metalloprotease digestion. Release of peptides varied as a function of time, enzyme specificity, and abundance. Specific type II collagen peptide biomarkers, including those containing the three-quarter-length fragment cleavage site and those containing the domains for helical peptide of type II collagen and C-telopeptide of type II collagen, were observed after release by selected proteases. CONCLUSION: The use of intact cartilage instead of purified protein substrates in the assay allowed for the identification of novel potential substrates and cleavage sites for individual enzymes under more physiologically relevant conditions. Characterization of these cartilage matrix peptides may help in the development of pharmacodynamic biomarkers of cartilage degradation, and also may contribute to an understanding of the bioactive peptides important in chondrocyte signaling. 相似文献
36.
DC Bosanquet CN Jones N Gill P Jarvis MH Lewis 《Annals of the Royal College of Surgeons of England》2013,95(1):15-19
Introduction
Numerous strategies are employed routinely in an effort to lower rates of surgical site infections (SSIs). A laminar flow theatre environment is generally used during orthopaedic surgery to reduce rates of SSIs. Its role in vascular surgery, especially when arterial bypass grafts are used, is unknown.Methods
A retrospective review of a prospectively maintained database was undertaken for all vascular procedures performed by a single consultant over a one-year period. Cases were performed, via random allocation, in either a laminar or non-laminar flow theatre environment. Demographic data, operative data and evidence of postoperative SSIs were noted. A separate subgroup analysis was undertaken for patients requiring an arterial bypass graft. Univariate and multivariate logistical regression was undertaken to identify significant factors associated with SSIs.Results
Overall, 170 procedures were analysed. Presence of a groin incision, insertion of an arterial graft and a non-laminar flow theatre were shown to be predictive of SSIs in this cohort. In the subgroup receiving arterial grafts, only a non-laminar flow theatre environment was shown to be predictive of an SSI.Conclusions
This study suggests that laminar flow may reduce incidences of SSI, especially in the subgroup of patients receiving arterial grafts. 相似文献37.
38.
39.
40.
de Koning JP; Dong F; Smith L; Schelen AM; Barge RM; van der Plas DC; Hoefsloot LH; Lowenberg B; Touw IP 《Blood》1996,87(4):1335-1342